Invion | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

919 results for “Invion”

Trials

View all 630 →

The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect

5 participants · First posted Nov 14, 2012

Study of PEG-Intron for Plexiform Neurofibromas

86 participants · First posted Nov 6, 2006

High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)

32 participants · First posted Apr 6, 2007

Drugs

View all 133 →

IVX-P02

Heat shock protein 10(Invion Ltd.)

Onion

Organizations

View all 35 →

Inion Oy

Finland

PT. DAEWOONG INFION

Indonesia

INVIVO THERAPEUTICS

United States

News

View all 121 →

Invion Doses First Patient in Phase I/II Trial of INV043 for Non-Melanoma Skin Cancer

Invion Doses First Patient in Phase I/II Non-Melanoma Skin Cancer Trial with INV043

Invion's INV043 Receives FDA Orphan Drug Designation for Anal Cancer Treatment

Page 1 of 92